Neutrophil-to-Lymphocyte Ratio as a Prognosticator in Targeted Therapy for Metastatic Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Change in Neutrophil-to-Lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy
Eur Urol 2016 Feb 26;[EPub Ahead of Print], AJ Templeton, JJ Knox, X Lin, R Simantov, W Xie, N Lawrence, R Broom, AP Fay, B Rini, F Donskov, GA Bjarnason, M Smoragiewicz, C Kollmannsberger, R Kanesvaran, N Alimohamed, T Hermanns, JC Wells, E Amir, TK Choueiri, DY HengFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.